Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 21, 2003
Grant Date -
Oct 4, 2001
app pub date -
Jan 17, 2001
filing date -
Sep 25, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to pharmaceutical compositions for the treatment of spinal disorders caused by the liberation of TNF-.alpha. comprising an effective amount of a TNF-.alpha. inhibitor, as well as a method for treatment of such disorders, and the use of TNF-.alpha. inhibitors in the preparation of pharmaceutical compositions for such treatment.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully